Park Place Capital’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-468
Closed -$24.5K – 736
2026
Q1
$24.5K Hold
468
– – ﹤0.01% 459
2025
Q4
$27.5K Hold
468
– – 0.01% 416
2025
Q3
$26K Sell
468
-144
-24% -$7.71K 0.01% 419
2025
Q2
$31.9K Buy
612
+144
+31% +$7.24K 0.01% 404
2025
Q1
$27.4K Hold
468
– – 0.01% 418
2024
Q4
$33.7K Hold
468
– – 0.01% 402
2024
Q3
$37.4K Sell
468
-52
-10% -$3.91K 0.01% 406
2024
Q2
$37.3K Hold
520
– – 0.01% 400
2024
Q1
$36.6K Hold
520
– – 0.01% 452
2023
Q4
$40.1K Sell
520
-32
-6% -$2.11K 0.02% 445
2023
Q3
$37.6K Hold
552
– – 0.01% 522
2023
Q2
$45.1K Hold
552
– – 0.01% 506
2023
Q1
$41K Hold
552
– – 0.01% 514
2022
Q4
$46K Buy
+552
New +$43.8K 0.01% 496

Other funds holding TECH

Park Place Capital's TECH Position: Q2 2026 in Review

Park Place Capital sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 468 shares — an estimated $24.5K sold.

Park Place Capital first reported a position in TECH in Q4 2022 and held it in 14 quarters. The position peaked at $46K in Q4 2022. 602 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Park Place Capital reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Park Place Capital sold 468 Bio-Techne shares in Q2 2026, an estimated $24.5K.
  • Park Place Capital first reported a position in Bio-Techne in Q4 2022 and held it in 14 quarters.
  • Park Place Capital's Bio-Techne position peaked at $46K in Q4 2022.
  • 602 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.